Jafron Biomedical Co.,Ltd. (300529.SZ)
CNY 30.04
(-0.07%)
CNY 30.04
(-0.07%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.13 Billion CNY | 11.49% |
| 2022 | -1.28 Billion CNY | 8.49% |
| 2021 | -1.4 Billion CNY | 9.25% |
| 2020 | -1.54 Billion CNY | -27.45% |
| 2019 | -1.21 Billion CNY | -24.49% |
| 2018 | -973.63 Million CNY | -5.34% |
| 2017 | -924.26 Million CNY | -21.6% |
| 2016 | -760.08 Million CNY | -164.39% |
| 2015 | -287.48 Million CNY | -23.46% |
| 2014 | -232.85 Million CNY | 6.25% |
| 2013 | -248.36 Million CNY | -14.27% |
| 2012 | -217.35 Million CNY | -24.0% |
| 2011 | -175.28 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -557.56 Million CNY | 50.89% |
| 2024 Q3 | 799.41 Million CNY | 1065.79% |
| 2024 Q2 | 68.66 Million CNY | 112.31% |
| 2023 Q4 | -1.13 Billion CNY | -17.66% |
| 2023 FY | -1.13 Billion CNY | 11.49% |
| 2023 Q3 | -964.98 Million CNY | 12.26% |
| 2023 Q2 | -1.09 Billion CNY | 24.9% |
| 2023 Q1 | -1.46 Billion CNY | -14.16% |
| 2022 Q2 | -1 Billion CNY | 35.06% |
| 2022 Q1 | -1.54 Billion CNY | -9.98% |
| 2022 FY | -1.28 Billion CNY | 8.49% |
| 2022 Q4 | -1.28 Billion CNY | -36.52% |
| 2022 Q3 | -939.65 Million CNY | 6.15% |
| 2021 Q2 | -1.54 Billion CNY | 4.94% |
| 2021 FY | -1.4 Billion CNY | 9.25% |
| 2021 Q1 | -1.62 Billion CNY | -4.41% |
| 2021 Q3 | -383.38 Million CNY | 75.21% |
| 2021 Q4 | -1.4 Billion CNY | -265.66% |
| 2020 Q2 | -1.23 Billion CNY | -14.63% |
| 2020 FY | -1.54 Billion CNY | -27.45% |
| 2020 Q1 | -1.08 Billion CNY | 15.01% |
| 2020 Q4 | -1.55 Billion CNY | -78.43% |
| 2020 Q3 | -873.38 Million CNY | 29.51% |
| 2019 Q1 | -1.13 Billion CNY | -5.3% |
| 2019 Q2 | -1.02 Billion CNY | 9.71% |
| 2019 Q3 | -132.86 Million CNY | 87.07% |
| 2019 Q4 | -1.27 Billion CNY | -857.13% |
| 2019 FY | -1.21 Billion CNY | -24.49% |
| 2018 FY | -973.63 Million CNY | -5.34% |
| 2018 Q4 | -1.08 Billion CNY | -7.46% |
| 2018 Q3 | -1 Billion CNY | 0.49% |
| 2018 Q2 | -1.01 Billion CNY | 10.74% |
| 2018 Q1 | -1.13 Billion CNY | -6.67% |
| 2017 Q1 | -545.77 Million CNY | 28.19% |
| 2017 FY | -924.26 Million CNY | -21.6% |
| 2017 Q4 | -1.06 Billion CNY | -355.15% |
| 2017 Q3 | -233.25 Million CNY | 77.32% |
| 2017 Q2 | -1.02 Billion CNY | -88.43% |
| 2016 FY | -760.08 Million CNY | -164.39% |
| 2016 Q3 | -579.45 Million CNY | -77.67% |
| 2016 Q2 | -326.14 Million CNY | -7.54% |
| 2016 Q1 | -303.26 Million CNY | -5.49% |
| 2016 Q4 | -760.08 Million CNY | -31.17% |
| 2015 Q1 | 232.85 Million CNY | 0.0% |
| 2015 FY | -287.48 Million CNY | -23.46% |
| 2015 Q4 | -287.48 Million CNY | 0.0% |
| 2015 Q2 | -235.92 Million CNY | -201.32% |
| 2014 FY | -232.85 Million CNY | 6.25% |
| 2013 FY | -248.36 Million CNY | -14.27% |
| 2012 FY | -217.35 Million CNY | -24.0% |
| 2011 FY | -175.28 Million CNY | 0.0% |